Similarly, Rigau reported that PSMA (AUC 0.74) outperformed PSGR (AUC 0.66) and PCA3 (AUC 0.61) in predicting PCa within the PSA “gray zone” of 4–10 ng/mL [21]. Here, OR51E2 is linked to posterior cortical atrophy.